Chiltern International’s programme of executive recruitment is continuing apace with the announcement that Ajaz Qureshi has joined the firm’s Slough-based headquarters as a further Early Phase Business Development Executive in its expanding team.
Ajaz has joined Chiltern after a four and a half year period with Quintiles, where he began by working with the clinical team running Phase I clinical trials and then moved into Business Development as an Associate. Here, he gained valuable expertise selling Phase I studies to some of the leading pharmaceutical companies.
He is the latest in a series of business development appointments made by the company throughout mainland and continental
Ajaz believes the industry will be impressed with Chiltern’s expertise in relation to the new European Union Directive, commenting: “One of the critical issues facing everyone in the industry is the implementation of the EU Directive on Phase I clinical trials. Chiltern International has worked hard to be able to offer the industry the regulatory support to ensure Phase I studies can be conducted in the
The company offers clinical contract personnel services to pharmaceutical and biotechnology clients. It has twelve international offices – three in the
For more information:
Last updated on: 27/08/2010